These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 21778236

  • 1. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation.
    Chen S, Bellew C, Yao X, Stefkova J, Dipp S, Saifudeen Z, Bachvarov D, El-Dahr SS.
    J Biol Chem; 2011 Sep 16; 286(37):32775-89. PubMed ID: 21778236
    [Abstract] [Full Text] [Related]

  • 2. Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.
    Chen S, Yao X, Li Y, Saifudeen Z, Bachvarov D, El-Dahr SS.
    Development; 2015 Mar 15; 142(6):1180-92. PubMed ID: 25758227
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos.
    Ma P, Schultz RM.
    Dev Biol; 2008 Jul 01; 319(1):110-20. PubMed ID: 18501342
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L, Katryniok C, Schnur N, Sorg BL, Metzner J, Grez M, Steinhilber D.
    J Cell Mol Med; 2012 Jul 01; 16(7):1461-73. PubMed ID: 21883892
    [Abstract] [Full Text] [Related]

  • 8. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.
    Fass DM, Reis SA, Ghosh B, Hennig KM, Joseph NF, Zhao WN, Nieland TJ, Guan JS, Kuhnle CE, Tang W, Barker DD, Mazitschek R, Schreiber SL, Tsai LH, Haggarty SJ.
    Neuropharmacology; 2013 Jan 01; 64():81-96. PubMed ID: 22771460
    [Abstract] [Full Text] [Related]

  • 9. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
    Liu ZH, Li J, Xia J, Jiang R, Zuo GW, Li XP, Chen Y, Xiong W, Chen DL.
    Chem Biol Interact; 2015 Dec 05; 242():227-34. PubMed ID: 26482938
    [Abstract] [Full Text] [Related]

  • 10. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
    Hu X, Lu X, Liu R, Ai N, Cao Z, Li Y, Liu J, Yu B, Liu K, Wang H, Zhou C, Wang Y, Han A, Ding F, Chen R.
    J Biol Chem; 2014 Aug 15; 289(33):23154-23167. PubMed ID: 24939842
    [Abstract] [Full Text] [Related]

  • 11. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.
    Urol Oncol; 2013 Nov 15; 31(8):1770-9. PubMed ID: 22944197
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
    Dejligbjerg M, Grauslund M, Litman T, Collins L, Qian X, Jeffers M, Lichenstein H, Jensen PB, Sehested M.
    Mol Cancer; 2008 Sep 12; 7():70. PubMed ID: 18789133
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis.
    Song R, Van Buren T, Yosypiv IV.
    Pediatr Res; 2010 Jun 12; 67(6):573-8. PubMed ID: 20496471
    [Abstract] [Full Text] [Related]

  • 16. HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes.
    Barter MJ, Pybus L, Litherland GJ, Rowan AD, Clark IM, Edwards DR, Cawston TE, Young DA.
    Matrix Biol; 2010 Sep 12; 29(7):602-12. PubMed ID: 20470885
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
    Obier N, Uhlemann CF, Müller AM.
    Cytotherapy; 2010 Nov 12; 12(7):899-908. PubMed ID: 20210674
    [Abstract] [Full Text] [Related]

  • 18. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
    Myzak MC, Karplus PA, Chung FL, Dashwood RH.
    Cancer Res; 2004 Aug 15; 64(16):5767-74. PubMed ID: 15313918
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC.
    J Cancer Res Ther; 2014 Aug 15; 10(3):469-78. PubMed ID: 25313724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.